Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Dermatology Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Dermatology Other
    Blood Flow Cytometry May Be Preferable Way to Diagnose, Analyse Mycosis Fungoides: Presented at ASCP - (DGDispatch)
    Converting to Sirolimus From Calcineurin Inhibitors Reduces Risk of Skin Cancer in Kidney Transplant Patients: Presented at Renal Week 2009 - (DGDispatch)
    Spinosad Better Than Permethrin for Pediculosis Capitis in Children: Presented at AAP - (DGDispatch)
    Topical Onychomycosis Treatment More Effective Than Oral Treatment : Presented at EADV - (DGDispatch)
    Mycophenolate Mofetil Benefits Patients With Pemphigus Vulgaris: Presented at EADV - (DGDispatch)

    News archive

     Recent webcasts/CME - Dermatology Other
      Adverse Cutaneous Reactions Induced by TNF-[alpha] Antagonist Therapy
      Advancements in Enzymatic Debridement: Applying Clinical Science to Everyday Applications
      The Prevention and Treatment of Pressure Ulcers
      Contemporary Options for the Management of Scars
      Pediatric and Adolescent Sports-Related Injuries and Ailments

      Webcasts/CME archive

       Recent cases - Dermatology Other
        Something Fishy
        Russell Bodies in a Skin Biopsy: A Case Report
        Yellow Nail Syndrome
        Acquired Perforating Dermatosis: Association with Diabetes and Renal Failure
        Complete Remission of Severe Idiopathic Cold Urticaria on Interleukin-1 Receptor Antagonist (Anakinra)

        Cases archive
          




        my personal edition > dermatology other > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Chronic Urticaria Remission More Likely After Helicobacter Pylori Eradication

        A DGReview of :"The effect of antibiotic therapy for patients infected with Helicobacter pylori who have chronic urticaria"
        Journal of the American Academy of Dermatology

        11/28/2003
        By Jill Taylor


        Resolution of chronic urticaria in patients infected with Helicobacter pylori is more likely to occur after eradication of H. pylori infection than when eradication is not achieved.

        Chronic urticaria is a common clinical disorder for which a variety of potential causes have been implicated. Recently, attention has turned to H. pylori as having a potential role in the pathogenesis of chronic urticaria.

        Previous studies of H. pylori that targeted antibiotic therapy for the treatment of chronic urticaria reported conflicting results. To further evaluate treatment of H. pylori in individuals with chronic idiopathic urticaria, Daniel G. Federman, MD, Yale University School of Medicine, New Haven, Connecticut, United States, and colleagues conducted a systematic literature review of MEDLINE and Cochrane Libraries.

        Ten studies met selection criteria, and included patients with urticaria persisting 6 weeks or more, excluded other known causes of urticaria, an initial diagnosis of H. pylori infection by serology, urea breath test findings, or upper endoscopy, and trial completion of an antibiotic regimen with known activity against H. pylori. Patients ranged in age from 10 to 82 years.

        Results of this review show that a 30.9% summary rate of urticaria remission when H. pylori was eradicated was, compared to 21.7% when H. pylori infection persisted. Among H. pylori negative controls, the background urticaria remission rate was 13.5%.

        When data across studies was combined, H. pylori eradication was associated with urticaria remission, with an odds ratio of 2.9 (95% confidence interval [CI] 1.4-6.8; P = .005). Similar results were observed when patients treated with placebo were excluded from analysis.

        Comparing patients whose H. pylori was eradicated and H. pylori negative controls, the odds ratio for urticaria remission was 4.7 (95% CI 2.6-17.6, P < .001).

        The results of this review suggest that after considering other causes of chronic urticaria, clinicians should test these patients for H. pylori infection, provide positive patients with antibiotic treatment, and confirm infection eradication, the researchers conclude.
        J Am Acad Dermatol 2003 Nov;49:5:861-4. "The effect of antibiotic therapy for patients infected with Helicobacter pylori who have chronic urticaria"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send